Treating Benign Paroxysmal Positional Vertigo (BPPV) in ED Patients
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT00641797|
Recruitment Status : Completed
First Posted : March 24, 2008
Results First Posted : April 3, 2018
Last Update Posted : April 3, 2018
|Condition or disease||Intervention/treatment||Phase|
|Benign Paroxysmal Positional Vertigo||Drug: Meclizine Other: Epley Maneuver Drug: Lorazepam Drug: Diphenhydramine Drug: Ondansetron||Not Applicable|
Show Detailed Description
|Study Type :||Interventional (Clinical Trial)|
|Actual Enrollment :||26 participants|
|Intervention Model:||Parallel Assignment|
|Masking:||Single (Care Provider)|
|Official Title:||A Randomized Trial to Evaluate Resolution of Symptoms Using Vestibular Rehab Versus Conventional Therapy in Patients Presenting to the Emergency Department (ED) With Diagnosis of Benign Paroxysmal Positional Vertigo (BPPV)|
|Study Start Date :||November 2006|
|Actual Primary Completion Date :||December 2010|
|Actual Study Completion Date :||November 2013|
Active Comparator: Arm 1, Conventional Therapy
Patients will receive standard conventional medication therapy (i.e., meclizine, diphenhydramine, lorazepam, ondansetron).
medication administration 25mg PO one time
Other Name: Antivert
Lorazepam 1 - 5mg PO/IV prn
Other Name: Valium
25 - 50mg PO/IV once prn
Other Name: Benedryl
Ondansetron 4 - 8 mg PO/IV prn
Other Name: Zofran
Experimental: Arm 2, Epley Maneuver
Patients will receive vestibular rehabilitation (the Epley Maneuver).
Other: Epley Maneuver
Patient has vestibular rehabilitation utilizing the Epley Maneuver.
Other Name: Canalith Repositioning Technique
- Likert Scale for Satisfaction [ Time Frame: 0 days ]The Likert Scale measured patient satisfaction on a 0-10 score range (0 = Least Satisfied; 10 = Most Satisfied).
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00641797
|United States, Pennsylvania|
|Lehigh Valley Hospital|
|Allentown, Pennsylvania, United States, 18103|
|Principal Investigator:||David B. Burmeister, DO||Lehigh Valley Hospital|